共 50 条
- [1] Tofacitinib for Induction Therapy in Patients with Active Ulcerative Colitis in Two Phase 3 Clinical Trials: Results by Local and Central Endoscopic Assessments [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S319 - S320
- [2] Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore [J]. BMC Gastroenterology, 23
- [4] Evaluation of the Efficacy of Tofacitinib as Maintenance Therapy in Patients With Ulcerative Colitis Stratified by OCTAVE Sustain Baseline Endoscopic Subscore [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S340 - S340
- [5] Evaluation of the efficacy of tofacitinib as maintenance therapy in patients with Ulcerative Colitis stratified by OCTAVE Sustain baseline endoscopic subscore [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S094 - S095
- [7] Time to Loss of Efficacy Following Tofacitinib Interruption in Patients With Ulcerative Colitis: Results From OCTAVE Sustain [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S405 - S406
- [9] Efficacy and safety of oral tofacitinib as maintenance therapy in patients with moderate to severe ulcerative colitis: results from a phase 3 randomised controlled trial [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S19 - S20